Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients

BACKGROUND/AIMS: The risk of hepatitis B virus reactivation in patients with a previously resolved hepatitis B virus infection on therapy with corticosteroids and conventional synthesis immunosuppressants for kidney disease has not been well described. MATERIALS AND METHODS: We performed a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Pingyang, Wang, Ziqiu, Wang, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Gastroenterology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645278/
https://www.ncbi.nlm.nih.gov/pubmed/37681265
http://dx.doi.org/10.5152/tjg.2023.22511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645278/
https://www.ncbi.nlm.nih.gov/pubmed/37681265
http://dx.doi.org/10.5152/tjg.2023.22511

Ejemplares similares